SVOAX | VIVIX | SVOAX / VIVIX | |
Total Expense Ratio | 0.90 | 0.04 | 2,250% |
Annual Report Gross Expense Ratio | 1.23 | 0.04 | 3,075% |
Fund Existence | 21 years | 27 years | - |
Gain YTD | 9.834 | 10.748 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 551M | 208B | 0% |
Annual Yield % from dividends | 1.26 | 2.09 | 60% |
Returns for 1 year | -4.75 | 8.21 | -58% |
Returns for 3 years | 5.14 | 49.10 | 10% |
Returns for 5 years | -0.36 | 73.42 | -0% |
Returns for 10 years | 3.95 | 132.88 | 3% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MARM | 32.61 | -0.01 | -0.04% |
FT Vest U.S. Eq Max Buffr ETF - Mar | |||
HEGD | 25.01 | -0.08 | -0.32% |
Swan Hedged Equity US Large Cap ETF | |||
PSFO | 31.77 | -0.13 | -0.40% |
Pacer Swan SOS Flex (October) ETF | |||
IHI | 59.96 | -0.35 | -0.58% |
iShares US Medical Devices ETF | |||
GLOW | 30.37 | -0.18 | -0.60% |
VictoryShares WestEnd Global Equity ETF |